Mark W. Grinstaff

Mark W. Grinstaff (born May 23, 1965) is a Distinguished Professor of translational research, Professor of biomedical engineering, chemistry, materials science, engineering and medicine, at Boston University, director of the National Institutes of Health's T32 Program in Biomaterials, Director of Nanotechnology Innovation Center, and Associate Director for Engineering and Science at the BU Cancer Center.

Mark W. Grinstaff
Born (1965-05-23) May 23, 1965
Texas
Alma materOccidental College
University of Illinois at Urbana–Champaign
Scientific career
FieldsTranslational research
Biomedical engineering
Chemistry
Material science
InstitutionsDuke University
Boston University
National Institutes of Health

Early life and education

Grinstaff was born on May 23, 1965 in Texas and was the elder of two sons.[1][2] Grinstaff attended Redlands High School in Redlands, California, and then Occidental College. During his first year at OC, he worked at the hummingbird section of a museum, at the same time studying studied the kinetics of Friedel-Crafts chloromethylation reactions in the laboratory of Franklin DeHaan who was also his mentor there. He then became teaching assistant in a chemistry lab class. During his junior year at the Occidental College he finally made up his mind and decided to pursue chemistry over medicine.[2] He obtained a degree in that field in 1987.[3]

In 1992, Grinstaff got his doctorate from the University of Illinois at Urbana–Champaign[3] , under the mentorship of Kenneth S. Suslick. While at UIUC he studied sonochemistry and reported one of the first synthetic methods to metal nanoparticles. His thesis was on the use of sound waves to make amorphous iron and protein-microsphere compounds. For his postdoctoral work, he joined Harry B. Gray's laboratory at the California Institute of Technology where he conducted research on electron transfer chemistry in proteins and the mechanism of alkane hydroxylation using iron porphyrins and oxygen.[1]

Career

Grinstaff was a member of the Biological Chemistry program at Duke University from 1996 to 2002, and from 1997 to 2002 was a member of its Pharmacology Training Grant Program. In 1997, he joined the faculty of Duke's Center for Cellular and Biosurface Engineering, and since 1999 has served as an assistant professor of ophthalmology at Duke University Hospital. At Duke, he was also assistant professor of chemistry at the College of Arts and Sciences beginning in 1996, and from 2001 to 2003 was assistant professor of biomedical engineering at Duke's School of Engineering.[2]

In 2003, Grinstaff relocated to Boston University as part of the recruitment activities associated with the Whitaker Foundation Leadership Award granted to the Department of Biomedical Engineering at BU. He joined Boston University College of Arts and Sciences as associate professor of chemistry, with joint appointments at both Boston University School of Medicine and the Boston University College of Engineering. In 2004, he became a faculty member of the Boston University Center for Nanoscience and Nanobiotechnology, and later became its director in 2014.[2]

In 2015, Gristaff had obtained a grant from Bill & Melinda Gates Foundation with which he developed which became known as self-lubricating condoms.[4] Under his watch, as many as four biotech companies emerged and prospered: AcuityBio, Affinergy, Articular Biosciences and HyperBranch Medical Technology.[5] He is also a co-founder of five companies and an inventor of four products by the Adherus Surgical Sealants and OcuSeal.[6]

Grinstaff serves on an advisory board of the Syracuse Biomaterials Institute.[7]

In 2001, Grinstaff have written Proceedings from the Workshop on Nanoscience for the Soldier of which he was also principal investigator.[8]

Awards and honors
gollark: I just said it wasn't. Honestly.
gollark: Well, it's not cognitohazardous, so you should look at it for about 30 seconds for its nonanomalous effects to not take hold.
gollark: While you're here, check out this NON-COGNITOHAZARD!
gollark: Yes, although technically I mind-controlled gecko into doing so.
gollark: Pyrobot WILL suffer. Although Markov chains are really fast so honestly what is gecko doing.

References
  1. "Mark W. Grinstaff". Science History Institute. Retrieved May 24, 2019.
  2. "Mark W. Grinstaff" (PDF). The Pew Scholars Program in the Biomedical Sciences. Chemical Heritage Foundation. September 2005.
  3. "Mark W. Grinstaff". Boston University. Retrieved May 24, 2019.
  4. "New Self-Lubricating Condom Would Revolutionize Safe Sex". Boston University. October 18, 2018. Retrieved May 24, 2019.
  5. "Delivering Scientific Innovations to Critical Medical Needs". Boston University. May 2, 2016. Retrieved May 24, 2019.
  6. "Mark W. Grinstaff, PhD". Retrieved May 24, 2019.
  7. "Advisory Board Members". Syracuse Biomaterials Institute. Retrieved May 24, 2019.
  8. Grinstaff, Mark W. (2001). Proceedings from the Workshop on Nanoscience for the Soldier (PDF).
  9. "Nobel Laureate Signature Award for Graduate Education in Chemistry". American Chemical Society. Retrieved May 24, 2019.
  10. "Mark W. Grinstaff, Ph.D." The Pew Charitable Trusts. Retrieved May 24, 2019.
  11. "Mark Grinstaff receives CIMIT's Edward M. Kennedy Award for Healthcare Innovation". Boston University. October 26, 2008. Retrieved May 24, 2019.
  12. "Mark W. Grinstaff, Ph.D." AIMBE. Retrieved May 24, 2019.
  13. "Mark Grinstaff ('92) Named a National Academy of Inventors Charter Fellow". University of Illinois. January 10, 2013. Retrieved May 24, 2019.
  14. "Grinstaff Receives Inaugural DeLisi Award and Lecture". Boston University. March 16, 2015. Retrieved May 24, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.